Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptional heterogeneity of MDA-MBA-468 triple-negative breast cancer cells

ABSTRACT: Transcriptional heterogeneity of MDA-MBA-468 triple-negative breast cancer cells

PROVIDER: PRJNA765006 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR15997900_1.fastq.gz	Fastqsanger.gz
	SRR15997900_2.fastq.gz	Fastqsanger.gz
	SRR15998000_1.fastq.gz	Fastqsanger.gz
	SRR15998000_2.fastq.gz	Fastqsanger.gz
	SRR15997901_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 564

Similar Datasets

Transcriptional heterogeneity among MDA-MBA-468 triple-negative breast cancer cells

Project description:Transcriptional heterogeneity among MDA-MBA-468 triple-negative breast cancer cells

| PRJNA765012 | ENA

Transcriptional heterogeneity among subclonal populations of MDA-MBA-468 triple-negative breast cancer cells

Project description:Transcriptional heterogeneity among subclonal populations of MDA-MBA-468 triple-negative breast cancer cells

| PRJNA765010 | ENA

Lipid remodeling in response to methionine stress in MDA-MBA-468 triple-negative breast cancer cells

Project description:Methionine is an essential amino acid and critical precursor to the cellular methyl donor S-adenosylmethionine. Unlike non-transformed cells, cancer cells have a unique metabolic requirement for methionine and are unable to proliferate in growth media where methionine is replaced with its metabolic precursor, homocysteine. This metabolic vulnerability is common among cancer cells regardless of tissue origin and is known as “methionine dependence”, “methionine stress sensitivity”, or Hoffman effect. Here, we characterize the response of lipids to methionine stress in the triple negative breast cancer cell line MDA-MB-468 and its methionine stress insensitive derivative, MDA-MB-468res-R8. Lipidome analysis identified an immediate, global decrease in lipid abundances with the exception of triglycerides and an increase in lipid droplets in response to methionine stress specifically in MDA-MB468 cells. Furthermore, specific gene expression changes were observed as a secondary response to methionine stress in MDA-MB-468, resulting in a down-regulation of fatty acid metabolic genes and up-regulation of genes in the unfolded protein response pathway. We conclude that the extensive changes in lipid abundance during methionine stress is a direct consequence of the modified metabolic profile previously described in methionine stress sensitive cells. The changes in lipid abundance likely results in changes in membrane composition inducing the unfolded protein response we observe.

2020-08-11 | GSE155955 | GEO

Transcriptional heterogeneity among MDA-MBA-468 triple-negative breast cancer cells

Project description:Intratumoral heterogeneity has been described for various tumor types and models of human cancer, and can have profound effects on tumor progression and drug resistance. This study describes transcriptional heterogeneity among subclonal populations (SCPs) derived from a single triple-negative breast cancer cell line.

2022-01-12 | GSE184542 | GEO

Lipid remodeling in response to methionine stress in MDA-MBA-468 triple-negative breast cancer cells

Project description:Lipid remodeling in response to methionine stress in MDA-MBA-468 triple-negative breast cancer cells

| PRJNA656377 | ENA

Transcriptional heterogeneity among xenograft tumors derived from subclonal populations of MDA-MBA-468 triple-negative breast cancer cells

Project description:Transcriptional heterogeneity among xenograft tumors derived from subclonal populations of MDA-MBA-468 triple-negative breast cancer cells

| PRJNA765011 | ENA

Transcriptional heterogeneity among subclonal populations of MDA-MBA-468 triple-negative breast cancer cells

2022-01-12 | GSE184540 | GEO

Transcriptional heterogeneity of MDA-MBA-468 triple-negative breast cancer cells

Project description:This SuperSeries is composed of the SubSeries listed below.

2022-01-12 | GSE184543 | GEO

RNA-seq analysis of triple negative breast cancer cell line MDA-MB-468 with knockdown of cytokeratin 5 (CK5)

Project description:MDA-MB-468 cells expressing pLK0-shControl or pLK0-shCK5-425222

2022-08-16 | GSE186262 | GEO

Lipid remodeling in response to methionine stress in MDA-MBA-468 triple-negative breast cancer cells.

Project description:Methionine (Met) is an essential amino acid and critical precursor to the cellular methyl donor S-adenosylmethionine. Unlike nontransformed cells, cancer cells have a unique metabolic requirement for Met and are unable to proliferate in growth media where Met is replaced with its metabolic precursor, homocysteine. This metabolic vulnerability is common among cancer cells regardless of tissue origin and is known as "methionine dependence", "methionine stress sensitivity", or the Hoffman effect. The response of lipids to Met stress, however, is not well-understood. Using mass spectroscopy, label-free vibrational microscopy, and next-generation sequencing, we characterize the response of lipids to Met stress in the triple-negative breast cancer cell line MDA-MB-468 and its Met stress insensitive derivative, MDA-MB-468res-R8. Lipidome analysis identified an immediate, global decrease in lipid abundances with the exception of triglycerides and an increase in lipid droplets in response to Met stress specifically in MDA-MB-468 cells. Furthermore, specific gene expression changes were observed as a secondary response to Met stress in MDA-MB-468, resulting in a downregulation of fatty acid metabolic genes and an upregulation of genes in the unfolded protein response pathway. We conclude that the extensive changes in lipid abundance during Met stress is a direct consequence of the modified metabolic profile previously described in Met stress-sensitive cells. The changes in lipid abundance likely results in changes in membrane composition inducing the unfolded protein response we observe.

| S-EPMC8042402 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data